Nexstim

Nexstim Q3'26: System deliveries point to a growth year

Analyst Comment2026-10-26 10:40

by Antti Siltanen

Nexstim Q3'26: System deliveries point to a growth year

On volume, system sales are clearly ahead of the comparison period.

Nexstim

Press release2026-10-23 08:00

Nexstim Plc Business Update Q3 2026

Nexstim

Press release2026-10-14 08:00

Nexstim and Brainlab Advance Neuroscience Capabilities in Portugal with Installation at Hospital da Luz Lisboa

Nexstim

Third party research2026-10-09 09:37

Nexstim: Conference feedback: Brainlab is set to scale NBS systems - NuWays AG Research

Paris MidCap conference feedback: Brainlab has the strategic fit and the installed base, to significantly scale Nexstim's NBS systems. Estimates unchanged. We remain with BUY and a PT of € 12.

Nexstim

Regulatory press release2026-10-02 13:00

Nexstim Plc: Managers’ Transactions, Laine

Nexstim

Press release2026-09-24 11:47

Analyst Group: Analyst Group Interview Nexstim’s CEO Mikko Karvinen

Nexstim

Press release2026-09-04 08:00

European University Hospital Orders Nexstim NBS 6 System

Nexstim

Press release2026-09-03 08:00

Nordic Private Clinic Expands Use with Additional NBS 6 System

Nexstim

Third party research2026-09-02 08:11

Nexstim: Stimulating growth with surgical accuracy; INITIATE with BUY - NuWays AG Research

Nexstim is a Finnish MedTech company and a global leader in navigated transcranial magneticstimulation (nTMS) technology. With nTMS, Nexstim helps (i) surgeons preserve patients' motor and speech cortices and (ii) clinicians treat neurological and psychiatric...

Nexstim

Press release2026-09-02 08:00